ZECCHETTO, CAMILLA
 Distribuzione geografica
Continente #
EU - Europa 1.674
NA - Nord America 1.622
AS - Asia 1.111
SA - Sud America 171
AF - Africa 37
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.620
Nazione #
US - Stati Uniti d'America 1.583
RU - Federazione Russa 742
SG - Singapore 390
CN - Cina 345
IT - Italia 236
BR - Brasile 142
GB - Regno Unito 142
DE - Germania 140
VN - Vietnam 127
HK - Hong Kong 92
IE - Irlanda 91
SE - Svezia 82
FR - Francia 75
FI - Finlandia 59
KR - Corea 37
CA - Canada 31
IN - India 25
NL - Olanda 23
JP - Giappone 18
AR - Argentina 13
AT - Austria 13
UA - Ucraina 13
BD - Bangladesh 12
ES - Italia 12
TR - Turchia 12
ID - Indonesia 9
PL - Polonia 9
ZA - Sudafrica 9
BE - Belgio 6
BJ - Benin 6
NG - Nigeria 6
SA - Arabia Saudita 6
TG - Togo 6
CZ - Repubblica Ceca 5
AU - Australia 4
EC - Ecuador 4
IQ - Iraq 4
JO - Giordania 4
LT - Lituania 4
MX - Messico 4
PT - Portogallo 4
UZ - Uzbekistan 4
HR - Croazia 3
NO - Norvegia 3
PK - Pakistan 3
PY - Paraguay 3
TH - Thailandia 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.620
Città #
Moscow 302
Ashburn 289
Dallas 255
Singapore 224
Chandler 182
San Jose 134
Dublin 91
Hong Kong 91
Southend 86
Verona 69
Beijing 58
Munich 58
The Dalles 55
Ho Chi Minh City 46
New York 36
Los Angeles 33
Jacksonville 30
Helsinki 27
São Paulo 27
Turku 25
Jinan 24
Woodbridge 22
Hanoi 21
Tianjin 20
Lawrence 19
London 19
Princeton 19
Milan 18
Orem 17
Wilmington 17
Houston 16
Rome 16
Shenyang 15
Tokyo 15
Buffalo 14
Frankfurt am Main 14
Montreal 14
Taiyuan 14
Columbus 13
Denver 13
Santa Clara 12
Sindelfingen 12
Toronto 12
Atlanta 11
Seattle 10
Ann Arbor 9
Barnet 9
Da Nang 9
Redondo Beach 9
Stockholm 9
Taizhou 9
Amsterdam 8
Council Bluffs 8
Seoul 8
Washington 8
Changsha 7
Chicago 7
Jakarta 7
Johannesburg 7
Kent 7
Madrid 7
Monza 7
Paris 7
Phoenix 7
Redwood City 7
Vienna 7
Zhengzhou 7
Cotonou 6
Fuzhou 6
Haikou 6
Hangzhou 6
Lomé 6
Nanjing 6
Nuremberg 6
Warsaw 6
Abuja 5
Boston 5
Brussels 5
Chennai 5
Guangzhou 5
Hebei 5
Mumbai 5
Nanchang 5
Treviso 5
Amman 4
Bologna 4
Dhaka 4
Fairfield 4
Haiphong 4
Lancaster 4
Marseille 4
Ningbo 4
Redmond 4
Rio de Janeiro 4
Riyadh 4
San Francisco 4
Boardman 3
Brasília 3
Brescia 3
Brooklyn 3
Totale 2.838
Nome #
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 281
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 247
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 246
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 232
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 201
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 198
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 191
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 187
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 181
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 175
Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer 173
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 173
Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib 170
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 161
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 154
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion 153
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma 145
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer 141
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 135
Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma 134
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports 131
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 116
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear 113
Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers 111
Safety and activity of the TGF beta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer 108
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials 98
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 85
Totale 4.672
Categoria #
all - tutte 15.606
article - articoli 15.606
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 1 14 10
2021/2022225 18 83 8 20 3 6 0 13 7 4 12 51
2022/2023498 24 63 36 81 37 137 0 30 63 7 13 7
2023/2024392 7 25 23 48 34 64 62 39 8 25 43 14
2024/2025797 37 32 40 123 37 38 79 37 74 35 108 157
2025/20262.364 135 120 239 407 627 151 228 104 203 150 0 0
Totale 4.672